AVCNF - Avicanna Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
70
118
27
0
Operating Expenses
Research Development
649
457
24
0
Selling General and Administrative
17,360
7,812
2,525
30
Total Operating Expenses
18,606
8,442
2,612
30
Operating Income or Loss
-18,536
-8,324
-2,585
-30
Total Other Income/Expenses Net
533
1,024
-16
-
Income Before Tax
-17,949
-7,289
-2,600
-30
Income from Continuing Operations
-17,949
-7,289
-2,600
-30
Net Income
-17,613
-7,099
-2,600
-30
Net Income available to common shareholders
-18,110
-7,596
-2,600
-30
EBITDA
-
-8,151
-2,522
-30